Among the first group of genes identified by this screen, JMJD2B was of particular interest given the apparent paradox of being activated by p53, yet being recently reported to be overexpressed in numerous cancers (24,25) and involved in the disruption of pericentromeric heterochromatin that promotes chromosome instability (26). The gene discussed is TP53; the disease is cancer.